You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

double-hit

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Double Hit Lymphoma, Triple Hit Lymphoma Trial in Hangzhou (Selinexor+RCHOP)

Recruiting
  • Double Hit Lymphoma
  • Triple Hit Lymphoma
  • Hangzhou, Zhenjiang, China
    Zhejiang Cancer Hospital
Aug 2, 2023

Multiple Myeloma (MM), DLBCL, Not Otherwise Specified, Double Hit Lymphoma Trial in Spain (IDP-121)

Recruiting
  • Multiple Myeloma (MM)
  • +5 more
  • Santander, Cantabria, Spain
  • +4 more
Jun 19, 2023

Refractory Aggressive B-cell Lymphomas, Refractory B-Cell Non-Hodgkin Lymphoma, Aggressive B-cell NHL Trial in Boston

Not yet recruiting
  • Refractory Aggressive B-cell Lymphomas
  • +12 more
  • Boston, Massachusetts
  • +1 more
Oct 13, 2022

High-grade B-cell Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell Trial in Busan, Seoul (Sepantronium Bromide)

Not yet recruiting
  • High-grade B-cell Lymphoma
  • +8 more
  • Sepantronium Bromide
  • Busan, Korea, Republic of
  • +5 more
Feb 27, 2022

Lymphoma, Large B-Cell, Diffuse, Mantle Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Nanjing (Chidamide)

Active, not recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • +3 more
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Dec 30, 2021

Brain Concussion Trial in Philadelphia (Branched Chain Amino Acids, Placebo solution)

Recruiting
  • Brain Concussion
  • Branched Chain Amino Acids
  • Placebo solution
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Mar 22, 2022

DLBCL, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Tampa, Florida
  • +1 more
Jan 12, 2022

Lymphoma, Relapsed Lymphoma, Refractory Lymphoma Trial in United States (fimepinostat, Rituximab, venetoclax)

Completed
  • Lymphoma
  • +10 more
  • Los Angeles, California
  • +10 more
May 5, 2021

Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2022

Aging, Cerebral Palsy, Muscle Weakness Trial in Salamanca (INSPIRATORY MUSCLE TRAINING)

Completed
  • Aging
  • +5 more
  • INSPIRATORY MUSCLE TRAINING
  • Salamanca, Spain
    University of Salamanca
Sep 28, 2023

Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia Trial (VLX-1005, Placebo)

Not yet recruiting
  • Thrombocytopenia, Immune
  • Heparin Induced Thrombocytopenia
  • (no location specified)
Mar 24, 2023

Non Hodgkin Lymphoma, Lymphoma, B-Cell, High-grade B-cell Lymphoma Trial in Belgium, Netherlands (DA-EPOCH-R followed by

Active, not recruiting
  • Non Hodgkin Lymphoma
  • +4 more
  • DA-EPOCH-R followed by Nivolumab
  • Antwerpen, Belgium
  • +23 more
Mar 23, 2022

Behavior, Health, Child Obesity Trial in United States (Greenlight Plus, Greenlight)

Active, not recruiting
  • Behavior, Health
  • Child Obesity
  • Greenlight Plus
  • Greenlight
  • Stanford, California
  • +5 more
Jan 27, 2023

Pulmonary Disease, Chronic Obstructive Trial in Germany, United States (Tiotropium + olodaterol, Placebo)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Tiotropium + olodaterol
  • Placebo
  • Andalusia, Alabama
  • +25 more
Oct 20, 2021

Predict CNS Involvement in Diffuse Large B-Cell Lymphoma:Danish

Completed
  • Diffuse Large B Cell Lymphoma
  • +2 more
    • (no location specified)
    Dec 13, 2021

    Large B-cell Lymphoma, DLBCL, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial (Epcoritamab)

    Available
    • Large B-cell Lymphoma
    • +4 more
    • Epcoritamab
    • (no location specified)
    Feb 16, 2023

    Glaucoma, Open-Angle, Exercise Training, Microvascular Health Trial (Exercise Training, Lifestyle Counselling)

    Not yet recruiting
    • Glaucoma, Open-Angle
    • +2 more
    • Exercise Training
    • Lifestyle Counselling
    • (no location specified)
    Sep 21, 2023

    Presbyvestibulopathy Trial in Tonalá (L-arginine, Placebo)

    Recruiting
    • Presbyvestibulopathy
    • Tonalá, Jalisco, Mexico
      CUTonalá
    Jul 3, 2023

    Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Wuhan, Hubei, China
      Institute of Hematology, Union Hospital, Tongji Medical College,
    Nov 18, 2023

    Binocular Vision Disorder, Convergence Insufficiency, Headache Trial in United States (Neurolens spectacle lens, Placebo

    Recruiting
    • Binocular Vision Disorder
    • +3 more
    • Neurolens spectacle lens
    • Placebo spectacle lens
    • Phoenix, Arizona
    • +9 more
    Dec 1, 2021

    Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,

    Suspended
    • Burkitt Lymphoma
    • +4 more
    • Rituximab
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    HIV Trial (PVO, TS)

    Not yet recruiting
    • HIV
    • PVO
    • TS
    • (no location specified)
    Oct 18, 2022

    Lymphoma Trial in Houston (Ibrutinib)

    Terminated
    Has Results
    • Lymphoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Nov 6, 2018

    Brain Injuries Trial in Indianapolis (Intermittent hypoxia, Sham hypoxia)

    Recruiting
    • Brain Injuries
    • Intermittent hypoxia
    • Sham hypoxia
    • Indianapolis, Indiana
      Rehabilitation Hospital of Indiana
    Apr 30, 2021

    Systemic Sclerosis, Raynaud Phenomena Trial in Nijmegen (Methylprednisolone, sodium chloride)

    Unknown status
    • Systemic Sclerosis
    • Raynaud Phenomena
    • Nijmegen, Gelderland, Netherlands
      Radboudumc, Rheumatology department
    Nov 27, 2019